Advertisement

Related Videos

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Deborah Collyar: What's In It for Patients?

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Advertisement

Advertisement




Mar
20
Today In Oncology
AMA Survey Finds Rapid Growth in Physician AI Adoption
For Most Men With Prostate Cancer, Hormone Therapy With Postprostatectomy Radiotherapy Confers No Survival Benefit
High Cancer Burden Shifted From Urban to Rural Areas
Study Finds No Overall Increase in Cancer Risk After Medically Assisted Reproduction
SMFM Issues New Clinical Guidance for Cancer Diagnosis and Treatment During Pregnancy
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo